Immortal genome assumption significantly underestimates replication and death rates of Mycobacterium tuberculosis in mice and monkeys
Friesen, A.; Ganusov, V. V.
Show abstract
Immune correlates of protection against infection with Mycobacterium tuberculosis (Mtb) or against tuberculosis disease (TB) remain poorly defined. The ratio of colony forming units (CFUs) to chromosomal equivalents (CEQs), Z = CFUs/CEQs, recovered either from the whole lung (mice) or individual lesions (monkeys or rabbits) of Mtb-infected animals has been used as a metric for how effectively Mtb is killed in vivo. However, the contribution of bacterial killing to changes in the CFU/CEQ ratio during an infection has not been rigorously investigated. We developed alternative mathematical models to study the dynamics of CFUs, CEQs, and their ratio during an Mtb infection. We find that the ratio Z alone cannot be used to infer the death rate of bacteria, unless the dynamics of CEQs and CFUs are entirely uncoupled, which is biologically unreasonable and inconsistent with the view that CEQs reflect an accumulated burden of both viable and non-viable bacteria. Importantly, we estimate a decay rate of 3.6%/day (a half life of about 20 days) of Mtb H37Rv CEQs in B6 mice that is similar to 4%/day, previously found for Mtb Erdman in cynomolgus macaques. While the estimated Mtb DNA decay rate seems small, we found that estimated rates of Mtb replication and death/killing are still extremely sensitive even to slow decay of Mtb DNA, in part, because Mtb replication and death rates are also small especially during chronic phases of infection. By applying our models to data on Mtb dynamics during the first 3 weeks of infection in macaques, we provide evidence of substantial killing of Mtb bacteria, prior to arrival of adaptive immunity to the site of infection, challenging the previously established notion of non-dying bacteria in the absence of T cell immunity and granuloma formation. We also propose experiments that will allow more accurately to measure the rate of Mtb DNA loss, helping more rigorously quantify impact of immunity on within-host Mtb dynamics.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A computational model tracks whole-lung Mycobacterium tuberculosis infection and predicts factors that inhibit dissemination 96%
- Drug-target binding quantitatively predicts optimal antibiotic dose levels 95%
- Models of SIV rebound after treatment interruption that involve multiple reactivation events 95%
Similar papers in this journal
Similar papers in this journal
- Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants 94%
- Dynamically Linking Influenza Virus Infection Kinetics, Lung Injury, Inflammation, and Disease Severity 94%
- Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens 93%
Similar papers in this journal
- Examining face-mask usage as an effective strategy to control COVID-19 spread 95%
- Differences in COVID-19 cyclicity and predictability among U.S. counties and states reflect the effectiveness of protective measures 94%
- Identifying likely transmission pairs with pathogen sequence data using Kolmogorov Forward Equations; an application to M.bovis in cattle and badgers 94%
Similar papers in this journal
- Timing matters in Macrophage / CD4+ T cell interactions: An agent-based model comparing Mycobacterium tuberculosis host-pathogen interactions between latently infected and naïve individuals 96%
- Cell growth model with stochastic gene expression helps understand the growth advantage of metabolic exchange and auxotrophy 93%
- Chaperone-mediated stress-sensing in Mycobacterium tuberculosis enables fast activation and sustained response 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.